Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Chemomab Therapeutics Ltd. (formerly Anchiano Therapeutics Ltd.):
Chemomab Therapeutics Ltd. (formerly Anchiano Therapeutics Ltd.):
We consent to the use of our report dated March 16, 2021, with respect to the financial statements of Chemomab Ltd. incorporated herein by reference.
/s/ Somekh Chaikin Somekh Chaikin |
Certified Public Accountants (lsr.) |
Member Firm of KPMG International |
Tel Aviv, Israel
September 13, 2021